Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Verhamme

Showing results (11-20 of 359) with videos related to

Pageof 36
Sort By:
Thrombosis Journal|November 20, 2009
Hemostasis and inflammation: two of a kind?Peter Verhamme, Marc F Hoylaerts
Seminars in Thrombosis and Hemostasis|May 15, 2015
Coagulase Activity by Staphylococcus aureus: A Potential Target for Therapy?Marijke Peetermans, Peter Verhamme, Thomas Vanassche
Expert Review of Hematology|May 12, 2016
Reversal of dabigatran by idarucizumab: when and how?Thomas Vanassche, Andreas Greinacher, Peter Verhamme
European Heart Journal. Case Reports|November 13, 2023
Percutaneous embolization of pulmonary arteriovenous malformations in adult patient with Rendu-Osler-Weber: a case reportWouter Schutyser, Werner Budts, Peter Verhamme
Heart (British Cardiac Society)|October 5, 2010
Relapsing renovascular hypertension in a young woman caused by isolated abdominal aortitisThomas Vanassche, Jean-Pierre Lacquet, Peter Verhamme
European Heart Journal Supplements : Journal of the European Society of Cardiology|July 7, 2018
Betrixaban for prevention of venous thromboembolism in acute medically ill patientsJan Beyer-Westendorf, Peter Verhamme, Rupert Bauersachs
Seminars in Nephrology|January 17, 2024
Clotting of the Extracorporeal Circuit in Hemodialysis: Beyond Contact-Activated CoagulationMatthias M Engelen, Peter Verhamme, Thomas Vanassche
TH Open : Companion Journal to Thrombosis and Haemostasis|December 30, 2020
Anticoagulation for Patients with Venous Thromboembolism: When is Extended Treatment Required?Jeffrey I Weitz, Paolo Prandoni, Peter Verhamme
Expert Opinion on Pharmacotherapy|January 3, 2015
Pharmacotherapy with oral Xa inhibitors for venous thromboembolismThomas Vanassche, Christophe Vandenbriele, Kathelijne Peerlinck, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 3, 2022
<i>Staphylococcus aureus</i> and Neutrophil Extracellular Traps: The Master Manipulator Meets Its Match in ImmunothrombosisSeverien Meyers, Marilena Crescente, Peter Verhamme, et al.
Pageof 36

Showing results (11-20 of 359) with videos related to

Sort By:
Pageof 36
Thrombosis Journal|November 20, 2009
Hemostasis and inflammation: two of a kind?Peter Verhamme, Marc F Hoylaerts
Seminars in Thrombosis and Hemostasis|May 15, 2015
Coagulase Activity by Staphylococcus aureus: A Potential Target for Therapy?Marijke Peetermans, Peter Verhamme, Thomas Vanassche
Expert Review of Hematology|May 12, 2016
Reversal of dabigatran by idarucizumab: when and how?Thomas Vanassche, Andreas Greinacher, Peter Verhamme
European Heart Journal. Case Reports|November 13, 2023
Percutaneous embolization of pulmonary arteriovenous malformations in adult patient with Rendu-Osler-Weber: a case reportWouter Schutyser, Werner Budts, Peter Verhamme
Heart (British Cardiac Society)|October 5, 2010
Relapsing renovascular hypertension in a young woman caused by isolated abdominal aortitisThomas Vanassche, Jean-Pierre Lacquet, Peter Verhamme
European Heart Journal Supplements : Journal of the European Society of Cardiology|July 7, 2018
Betrixaban for prevention of venous thromboembolism in acute medically ill patientsJan Beyer-Westendorf, Peter Verhamme, Rupert Bauersachs
Seminars in Nephrology|January 17, 2024
Clotting of the Extracorporeal Circuit in Hemodialysis: Beyond Contact-Activated CoagulationMatthias M Engelen, Peter Verhamme, Thomas Vanassche
TH Open : Companion Journal to Thrombosis and Haemostasis|December 30, 2020
Anticoagulation for Patients with Venous Thromboembolism: When is Extended Treatment Required?Jeffrey I Weitz, Paolo Prandoni, Peter Verhamme
Expert Opinion on Pharmacotherapy|January 3, 2015
Pharmacotherapy with oral Xa inhibitors for venous thromboembolismThomas Vanassche, Christophe Vandenbriele, Kathelijne Peerlinck, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 3, 2022
<i>Staphylococcus aureus</i> and Neutrophil Extracellular Traps: The Master Manipulator Meets Its Match in ImmunothrombosisSeverien Meyers, Marilena Crescente, Peter Verhamme, et al.
Pageof 36